Compass Therapeutics IPO Set for $50 Million Nasdaq Offering
The Compass Therapeutics IPO is set to raise $50 million on November 13. But is Compass Therapeutics stock a good investment opportunity?
The Compass Therapeutics IPO is set to raise $50 million on November 13. But is Compass Therapeutics stock a good investment opportunity?
The best biotech IPOs and firms have been stomping on the gas pedal. In June alone, there were no less than 14 IPOs in the sector.
The Forma Therapeutics IPO launched on the Nasdaq market. And Forma Therapeutics stock could be the next hit. But is it a good investment opportunity?